Aridol Challenge as a Tool to Predict Treatment Response to Inhaled Corticosteroids in COPD

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

July 31, 2005

Study Completion Date

August 31, 2006

Conditions
Lung Diseases, Obstructive
Interventions
DRUG

Dry powder mannitol

DRUG

Budesonide 400mcg administered via turbuhaler

DRUG

Ipratropium bromide 80mcg

DRUG

Salbutamol 400mcg

Trial Locations (13)

2200

Respiratory Clinic, Sydney

2257

Peninsula Medical Centre, Umina

3004

The Alfred Hospital, Melbourne

3199

Peninsula Chest Clinic, Frankston

3220

The rooms of Dr Chris Steinfort, Geelong

3939

Rosebud Medical Centre, Rosebud

4066

Wesley Medical Centre, Auchenflower

4077

Inala Health Centre, PO BOx 52, Inala

4152

Brisbane South Clinical Clinical Research Centre, Brisbane

5042

Flinders University, Bedford Park

5056

Respiratory Research Foundation Clinical Trial Centre, Toorak Gardens

6005

Mount Medical Centre, Perth

6009

Sir Charles Gairdner Hospital, Nedlands

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Syntara

INDUSTRY